SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biogen -- Ignore unavailable to you. Want to Upgrade?


To: Harold Engstrom who wrote (679)6/22/1998 11:53:00 PM
From: Michelino  Respond to of 1686
 
Harold,

Sincere thanks for the meeting summary from those of that are mostly lurkers. You mentioned that "Merck has begun Phase II trials in Asthma patients...An oral delivery method is being worked on." Did you hear any details on the population that they are targeting? (ie: pts with Moderate or Severe asthma etc.)

Michael



To: Harold Engstrom who wrote (679)6/25/1998 11:08:00 AM
From: Hong-Lee Yu  Read Replies (1) | Respond to of 1686
 
All,

Check Lehman's research - upgrading to 1-BUY with target price of 60 based on increasing royalty from SGP.

lehman.com